Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is prevalent in patients with type 2 diabetes. Here, we estimate the proportion of patients with type 2 diabetes that should be referred to hepatologists according to the European Association for the Study of the Liver (EASL)-European Association...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Open Diabetes Res Care
Asıl Yazarlar: Ciardullo, Stefano, Muraca, Emanuele, Perra, Silvia, Bianconi, Eleonora, Zerbini, Francesca, Oltolini, Alice, Cannistraci, Rosa, Parmeggiani, Paola, Manzoni, Giuseppina, Gastaldelli, Amalia, Lattuada, Guido, Perseghin, Gianluca
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2020
Konular:
Clinical Care/Education/Nutrition
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039600/
https://ncbi.nlm.nih.gov/pubmed/32049637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000904
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller